Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Vancomycin + tobramycin antibiotic cement beads refer to a local antimicrobial delivery system used for the temporary management of severe open tibia fracture wounds. This intervention, primarily studied by the University of Maryland, Baltimore, involves incorporating generic vancomycin and tobramycin powders into polymethyl methacrylate (PMMA) cement to form beads. These beads are placed directly into the tissue defect of severe open fractures and sealed with a semipermeable membrane to create an 'antibiotic bead pouch.' This method allows for the local delivery of high therapeutic concentrations of antibiotics while minimizing systemic exposure and toxicity. Vancomycin, a glycopeptide, inhibits bacterial cell wall synthesis, while tobramycin, an aminoglycoside, inhibits bacterial protein synthesis. The approach is currently being evaluated in the Phase III 'Beads vs Vac' trial (NCT05615844) as a strategy to reduce complications such as infection, unplanned reoperation, and amputation in patients requiring multiple irrigation and debridement surgeries.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on vancomycin + tobramycin antibiotic cement beads.